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Introduction
Extracellular matrix (ECM) synthesis and degradation
plays and important role in the initiation, progression
and complication of atherosclerosis and in-stent resteno-
sis but also in aneurysm formation/degradation and graft
disease. Enhanced synthesis of ECM typically leads to
expansive or constrictive vessel wall remodeling resulting
in plaque stability but also arterial stenosis or in-stent res-
tenosis. In contrast, advanced ECM degradation can lead
to plaque instability and subsequent plaque rupture as
typically observed in patients with acute coronary syn-
dromes. In an animal study of left carotid artery injury,
enhanced collagen and elastin formation was found three
weeks post balloon angioplasty compared to the non-
injured control vessel.
Purpose
In this study we sought to demonstrate the feasibility of
non-invasive MR imaging of vascular remodeling in a
swine model of coronary injury using a novel elastin-
binding low molecular weight contrast agent,
BMS753951 (abstract 12957, AHA 2007: Bristol Myers
Squibb, Billerica, MA).
Methods
Vascular injury was induced in 6 female landrace pigs
(30–35 kg) by endothelial denudation (LCX) and stent
placement (LAD) or vice versa, followed by a 28 day nor-
mal diet. The RCA served as control vessel. Lasered MR-
lucent prototype stents (Aachen Resonance, Aachen, Ger-
many) were used to allow artifact free imaging of the stent
lumen and vessel wall. At day 28, free-breathing coronary
MRA and delayed enhancement imaging of the coronary
vessel walls was performed using a 1.5 T MR scanner
(Achieva, Philips Medical Systems, NL) pre and after
injection of 0.2 mmol/kg Gd-DTPA. Imaging parameters
of the free-breathing ECG triggered and navigator (NAV)
gated inversion recovery (IR) segmented gradient echo
vessel wall sequence included FOV = 320 mm, matrix =
256 × 256, in-plane resolution = 1.25 × 1.25 mm, slice
thickness = 3 mm, acquisition window = 50 ms, TR/TE =
4.7 ms/1.4 ms, flip angle = 30°, inversion time = 285 ms
(@ 90 bpm), and slices = 24. Two days later, coronary
MRA and delayed enhancement coronary vessel wall
imaging were repeated pre and post injection of 0.1
mmol/kg BMS753951 until two hours post injection.
After completion of MR imaging, x-ray coronary angiogra-
phy was performed to assess the degree of luminal steno-
sis in the stented and balloon injured vessel segment.
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concentration was determined by inductively coupled
plasma mass spectrometry (ICP-MS) in the ascending
aorta. For objective image analysis, contrast-to-noise ratio
(CNR) between vessel wall and blood was determined by
manual segmentation of the coronary vessel wall in the
stented, balloon injured and control vessels on reformat-
ted images.
Results
No visually apparent enhancement of the stented, balloon
injured and control coronary vessel segments was
observed after administration of Gd-DTPA (Figure 1b, e).
In contrast, after administration of BMS753951, strong
enhancement of the stented and intermediate enhance-
ment of the balloon injured coronary vessel segment were
observed suggestive for vascular remodeling in the injured
vessel segments (Figure 1c, f). There was no to little visu-
ally apparent enhancement in the control coronary artery
(Figure 1c). Quantitative analysis of vessel wall enhance-
ment yielded a 3-fold higher CNR in the stented coronary
artery when compared to the balloon injured and control
artery (p < 0.001) (Figure 2). In addition, strong aortic
and pulmonary vessel wall enhancement was seen after
BMS753951 administration, which is in agreement with
the high elastin content in those vessels, while no appar-
ent enhancement was observed after Gd-DTPA injection
(p < 0.001) (Figure 3). ICP-MS of aortic samples yielded a
gadolinium concentration of 0.29–0.52 mmol/L.
Conclusion
This is the first MRI study to demonstrate the detection of
ECM synthesis non-invasively in an animal model of cor-
onary vessel wall injury using an elastin-specific contrast
agent. This novel approach may be useful for in-vivo
monitoring of vascular remodeling post stent placement
or for the assessment of plaque burden in patients with
suspected coronary artery disease.
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Contrast-to-noise ratio (CNR) in stented, balloon injured, and con rol vess l af er administratio  of BMS753951Figu e 2
Contrast-to-noise ratio (CNR) in stented, balloon injured, 
and control vessel after administration of BMS753951.
We sought to demonstrate the feasibility of imaging vascular remodeling in a porcine model of coronary injury using BMS753951, a novel elastin-binding low m lec lar wei ht contrast a e tFigure 3
We sought to demonstrate the feasibility of imaging vascular 
remodeling in a porcine model of coronary injury using 
BMS753951, a novel elastin-binding low molecular weight 
contrast agent. (A) Vessel wall enhancement in the descend-
ing aorta and aortic arch approximately 50 minutes post 
BMS753951 injection. (B) No apparent enhancement was 
observed after Gd-DTPA injection.
